Skip to main content

Advertisement

SpringerLink
Log in

Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients—a randomized placebo-controlled trial

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Sickle-cell disease (SCD) patients are at high risk of developing malaria which is a major contributor to morbidity and mortality in this disease. In Senegal, malaria transmission is high during rainy season, between July and October, and it was noted that sickle-cell crisis are frequent during this period. Then we carried out a double-blind randomized controlled trial to compare the impact of monthly sulfadoxine-pyrimethamine (SP) during the high-transmission season versus placebo on malaria incidence and morbidity of sickle-cell anemia. Sixty (60) SCD patients were randomized either to receive three intermittent preventive treatment (ITP) with SP or placebo using the random permutation table with nine elements. The drug was administrated as follows: sulfadoxine 25 mg/kg and pyrimethamine 1.25 mg/kg and this treatment was given once during the following months: September, October, and November. Overall four episodes of malaria disease were diagnosed, all these cases in the placebo arm. Thus, overall prevalence was 6.6% and there was no other case of malaria in the SP arm during the study period. Parasitological diagnosis confirmed the presence of Plasmodium falciparum in all four cases. No patient death was encountered during the study. SP treatment was well tolerated as only one patient (1.6%) in the SP arm reported pruritis. A significant reduction of patients' complaints (p = 002) and blood requirements (p = 0.001) was noted in the SP group; whereas, no impact was observed on vaso-occlusive crisis and hospitalization occurrence. Malaria prophylaxis by monthly intake of SP during the transmission period of the parasite reduced the prevalence of malaria and was safe in SCD patients leaving in malaria endemic area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Modell B, Darlison M (2008) Global epidemiology of hemoglobin disorders and derived service indicators. Bull World Health Organ 86:480–487

    Article  PubMed  Google Scholar 

  2. Mbodj M, Ndoye O, Diarra M, Mbaye BN, Sow Toure H, Diouf L et al (2003) Sickle cell disease neonatal screening: first evaluation. Dak Med 48:202–205

    CAS  Google Scholar 

  3. World Health Organization (2006) Management of birth defects and hemoglobin disorders: report of a joint WHO-March of Dimes meeting. World Health Organ, Geneva

    Google Scholar 

  4. Adjuik M, Smith T, Clark S, Todd J, Garrib A, Kinfu Y et al (2006) Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ 84:181–188

    Article  PubMed  Google Scholar 

  5. May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T et al (2007) Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA 297(20):2220–2226

    Article  CAS  PubMed  Google Scholar 

  6. Diop S, Koffi G, N’Dahtz E, Allangba O, Aka Adjo MA, Sanogo I et al (1997) Infection in sickle cell disease. Bull Soc Path Ex 90:339–341

    CAS  Google Scholar 

  7. Serjeant GR (2005) Mortality from sickle cell disease in Africa. BMJ 330:432–433

    Article  PubMed  Google Scholar 

  8. Diop S, Ndiaye M, Seck M, Chevalier B, Jambou R, Sarr A et al (2009) Prevention of transfusion transmitted malaria in endemic area. Tranfus Clin Biol 16:454–459

    Article  CAS  Google Scholar 

  9. Fegan GW, Noor AM, Akhwale WS, Cousens S, Snow RW (2007) Effect of expanded insecticide-treated bed net coverage on child survival in rural Kenya: a longitudinal study. Lancet 370(9592):1035–1039

    Article  PubMed  Google Scholar 

  10. Manzi F, Hutton G, Schellenberg J, Tanner M, Alonso P, Mshinda H, Schellenberg D (2008) From strategy development to routine implementation: the cost of intermittent preventive treatment in infants for malaria control. BMC Health Serv Res 31:1–19

    Google Scholar 

  11. Committee on the Perspectives on the Role of Intermittent Preventive Treatment for Malaria in infants (2008) Assessment of the role on intermittent preventive treatment for malaria in infants: letter report. National Academies Press, Washington, DC

    Google Scholar 

  12. Cisse B, Sokhna C, Boulanger D, Milet J, Bâ EH, Richardson K et al (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomized, placebo-controlled, double-blind trial. Lancet 367:659–667

    Article  CAS  PubMed  Google Scholar 

  13. Briand V, Cottrell G, Massougbodji A, Cot M (2007) Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J 6:1–7

    Article  Google Scholar 

  14. Diop S, Mokono SO, Ndiaye M, Toure-Fall AO, Thiam D, Diakhaté L (2003) Homozygous sickle cell disease in patients above 20 years of age: follow-up of 108 patients in Dakar. Rev Med Intern 24:711–715

    Article  CAS  Google Scholar 

  15. Machault V, Gadiaga L, Vignolles C, Jarjaval F, Bouzid S, Sokhna C et al (2009) Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J 8:1–21

    Article  Google Scholar 

  16. Pasvol G (2009) Are children with homozygous sickle cell disease really at a disadvantage in the face of malaria? The malaria hypothesis revisited. Clin Infect Dis 49:223–224

    Article  PubMed  Google Scholar 

  17. Makani J, Komba AN, Kox SE, Oruo J, Mwamtemi K, Kitundu J et al (2010) Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood 115:215–220

    Article  CAS  PubMed  Google Scholar 

  18. Diallo D, Tchernia G (2002) Sickle cell disease in Africa. Curr Opin Hematol 9:111–116

    Article  PubMed  Google Scholar 

  19. Oniyangi O, Omari AA (2006) Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev 4:CD003489

    PubMed  Google Scholar 

  20. Tatfeng YM, Agbonlahor DE, Tchounga KS, Omolu PI, Okodua M, Yah CS et al (2008) Chloroquine prophylaxis associated with high prevalence of Plasmodium falciparum pfcrt K76T mutation in people with sickle-cell disease in Benin City, Nigeria. J Vector Borne Dis 45(1):51–55

    CAS  PubMed  Google Scholar 

  21. Warley MA, Hamilton DJS, Marsden PD, Brown RE, Merselis JG, Wilks N (1965) Chemoprophylaxis of homozygous sicklers with antimalarials and long acting penicillin. BMJ 5453:86–88

    Article  Google Scholar 

  22. Nakibuuka V, Ndeezi G, Nakiboneka D, Ndugwa CM, Tumwine JK (2009) Presumptive treatment with sulfadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anemia in Uganda: a randomized controlled trial. Malar J 8:223–228

    Article  Google Scholar 

  23. Eke FU, Anochie I (2003) Effects of pyrimethamine versus proguanil in malaria chemoprophylaxis in children with sickle cell disease, a randomized placebo controlled open label study. Curr Ther Res 64:C16–C25

    Article  Google Scholar 

  24. Watkins WM, Mberu EK, Winstanley PA, Plowe CV (1997) The efficacy of antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today 13:459–464

    Article  CAS  PubMed  Google Scholar 

  25. Sutherland CJ, Drakeley CJ, Schellenberg D (2007) How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions. Malar J 6:161

    Article  PubMed  Google Scholar 

  26. Gaye O, Tine RC, Ndiaye JL (2009) Enquête Nationale sur le Paludisme 2008–2009 (ENPS-II). Ministry of Health, Republic of Senegal

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Hematology, University Cheikh Anta Diop, BP 5002, Dakar-Fann, Senegal

    Saliou Diop, Fabienne Soudré, Moussa Seck, Youssou Bamar Guèye, Tandakha Ndiaye Diéye, Awa Oumar Touré Fall, Abibatou Sall, Doudou Thiam & Lamine Diakhaté

Authors
  1. Saliou Diop
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabienne Soudré
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moussa Seck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Youssou Bamar Guèye
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tandakha Ndiaye Diéye
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Awa Oumar Touré Fall
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Abibatou Sall
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Doudou Thiam
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lamine Diakhaté
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saliou Diop.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diop, S., Soudré, F., Seck, M. et al. Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients—a randomized placebo-controlled trial. Ann Hematol 90, 23–27 (2011). https://doi.org/10.1007/s00277-010-1040-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-1040-z

Keywords

Search

Navigation